B8299

N-Butyldeoxynojirimycin

film (dried in situ), ≥98% (TLC)

• Synonym(e): Miglustat, NB-DNJ
• Empirische Formel (Hill-System): C₁₀H₂₁NO₄
• CAS-Nummer: 72599-27-0
• Molekulargewicht: 219.28
• MDL-Nummer: MFCD00272581
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24892070
• NACRES: NA.32

Eigenschaften

• product name: N-Butyldeoxynojirimycin, film (dried in situ)
• Assay: ≥98% (TLC)
• Qualitätsniveau: 200
• Form: film (dried in situ)
• Löslichkeit: water: 9.80-10.20 mg/mL, clear, colorless
• Lagertemp.: 2-8°C
• SMILES String: CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
• InChI: 1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
• InChIKey: UQRORFVVSGFNRO-UTINFBMNSA-N
• Angaben zum Gen: human ... UGCG(7357)

Beschreibung

Allgemeine Beschreibung

N-Butyldeoxynojirimycin is an alkylated product of imino sugar deoxynojirimycin.

Anwendung

N-Butyldeoxynojirimycin has been used:

• in the inhibition of glycolipid synthesis in neuroblastoma cells
• in the inhibition the ceramide-specific glycosyltransferase in hepatocytes
• in the inhibition of β-glucosidase (GBA2) using fluorescence- activity assay in human embryonic kidney (HEK293) cells.

Biochem./physiol. Wirkung

N-Butyldeoxynojirimycin is an inhibitor of glucosyltransferase and α-glucosidases. N-Butyldeoxynojirimycin, also known as misglustat, reduces glycolipid levels by substrate reduction therapy (SRT) and is effectively used for the treatment of glycosphingolipid lysosomal storage disorder, Gaucher disease.

α-glucosidase Inhibitor

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)